Moreover, TF-targeted NIR-PIT demonstrated significant in vivo tumor control in murine xenograft models of pancreatic cancer and epithelioid cancer, as well as immunogenic cell death after treatment across multiple tumors. The gene discussed is TF; the disease is neoplasm.